Patent · US Active

Methods and compositions for in vitro and in vivo chondrogenesis

US8685386B2 · kind B2 · utility

20Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2010
Grant dateApr 1, 2014
Priority date
Expiry dateJul 16, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the present invention include methods and compositions related to the production, identification and use of embryonic progenitor cell lines that are capable of undergoing chondrogenesis. A number of exemplary chondrogenic cell lines derived from primordial stem cells are disclosed. The chondrogenic cell lines described herein are robust, can expand for >40 passages, and have site-specific purity, thus providing for compositions and methods of producing diverse cartilage types with unique molecular compositions for use in research and therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.